argenx to Present at BofA Securities 2022 Healthcare Conference

Rhea-AI Summary

argenx (ARGX) will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11, 2022, at 10:40 a.m. P.T. in Las Vegas, NV. The event will be accessible via a live webcast on the company's Investors section of the argenx website, with a replay available for 90 days post-event. argenx aims to develop innovative antibody-based medicines for severe autoimmune diseases and is known for its pioneering work with the neonatal Fc receptor (FcRn) blocker.

May 4, 2022

Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 10:40 a.m. P.T. in Las Vegas, NV.

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 90 days following the presentation.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S. and Japan. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Twitter, and Instagram.

For further information, please contact:

Media:

Kelsey Kirk
kkirk@argenx.com

Investors:

Beth DelGiacco
bdelgiacco@argenx.com

Michelle Greenblatt
mgreenblatt@argenx.com

FAQ

When is argenx participating in the BofA Securities 2022 Healthcare Conference?

argenx will participate in the BofA Securities 2022 Healthcare Conference on May 11, 2022, at 10:40 a.m. P.T.

Where can I watch the argenx presentation live?

The live webcast of the argenx presentation can be accessed on the Investors section of the argenx website.

How long will the argenx webcast replay be available?

A replay of the argenx webcast will be available for approximately 90 days following the presentation.

What is the focus of argenx's research and development?

argenx is focused on developing novel antibody-based medicines for severe autoimmune diseases.

What significant product has argenx developed in the U.S. and Japan?

argenx has developed the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S. and Japan.